CANCER PROGRESSION AND TUMOR CELL MOTILITY
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
stage, esophageal cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hepatoma resectable
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Childhood Gliomatosis Cerebri
|
disease |
Neoplasms
|
Neoplastic Process
|
9
|
6
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Gliomatosis cerebri
|
disease |
Neoplasms
|
Neoplastic Process
|
10
|
6
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Sotos' syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hyperphosphaturia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Bone Sarcoma
|
group |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
32
|
4
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Node-positive breast cancer
|
disease |
|
Neoplastic Process
|
40
|
3
|
0.010 |
None |
1.000 |
1 |
1
|
2006 |
2006 |
Breast cancer recurrent
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
41
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Perihilar Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
41
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Mandibulofacial Dysostosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
42
|
30
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Chromosome 5, trisomy 5q
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
42
|
1
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Phosphate Diabetes
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
51
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Situs ambiguus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Congenital Abnormality
|
55
|
9
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
von Willebrand's factor (lab test)
|
phenotype |
|
Laboratory Procedure
|
55
|
427
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Diarrhoea predominant irritable bowel syndrome
|
disease |
|
Disease or Syndrome
|
57
|
8
|
0.020 |
None |
1.000 |
2 |
2
|
2011 |
2012 |
Febrile Neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
58
|
14
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Childhood Alveolar Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
59
|
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2012 |
Limb Deformities, Congenital
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
59
|
4
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Growth Hormone-Secreting Pituitary Adenoma
|
disease |
Neoplasms; Nervous System Diseases; Endocrine System Diseases
|
Neoplastic Process
|
60
|
5
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Childhood Embryonal Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
67
|
7
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Tumors of Adrenal Cortex
|
group |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
74
|
5
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Cardiovascular morbidity
|
phenotype |
|
Disease or Syndrome
|
75
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adenoviral infections
|
group |
|
Disease or Syndrome
|
78
|
1
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |